Riskpilot
← Back to search
Sign in
Get full access
ExpMed Pharma Consulting AB
AB
In liquidation
Org 5568406069
Other education n.e.c.
· NACE 8559
Est. 2011
0 employees
Watchlist
Share
Sweden
/
Companies
/
Other education n.e.c.
/
ExpMed Pharma Consulting AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2016
0M
2017
0M
2018
0M
2019
0M
2020
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2016
0M
2017
0M
2018
0M
2019
0M
2020
Income statement
SEK thousands
Item
2016
2017
2018
2019
2020
Revenue
0
0
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
−13
−12
−23
53
−12
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−13
−12
−23
53
−12
Net financials
—
—
13
−4
99
Profit before tax
−4
333
522
49
87
Tax
−0
−74
−115
−11
−19
Net profit
−4
259
407
38
68
Balance sheet
SEK thousands
Item
2016
2017
2018
2019
2020
Total assets
2 279
2 288
2 281
2 286
306
Equity
1 310
1 405
1 642
1 510
119
Long-term debt
0
0
0
0
0
Short-term debt
94
351
639
776
186
Total debt
94
351
639
776
186
Financial ratios
5-year trend
EBITDA margin
-1200000.0%
This company
15.8%
Market median
-7595037% vs market
2016
2020
Equity ratio
38.9%
This company
38.2%
Market median
+2% vs market
2016
2020
Return on equity
57.1%
This company
18.4%
Market median
+210% vs market
2016
2020
Net profit margin
6800000.0%
This company
8.1%
Market median
+83950517% vs market
2016
2020
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2016
2020
Debt / equity
1.57×
This company
0.62×
Market median
-153% vs market
2016
2020
Annual reports & filings
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
View
PDF
Annual report 2017
Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
View
PDF
Annual report 2016
Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
View
PDF
Riskpilot